PTCT
PTC Therapeutics, Inc.
stockNASDAQ
At CloseOct 30, 2026 2:26:32 PM EDT
61.60USD-4.437%(-2.86)2,357,646
Pre-marketOct 30, 2026 10:29:59 AM EDT
63.13USD-2.063%(-1.33)
PTCT Financials
In Q3 FY 2026 (ended ), PTC Therapeutics, Inc. (PTCT) reported revenue of $357.81M, net income of −$51.69M, operating cash flow of −$25.31M, and assets of $3.21B.
Loading financial statements…